Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Finlabo SIM Spa
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

NextBio Announces Translational Medicine Partnership with Sanofi SA


Tuesday, 30 Apr 2013 08:00am EDT 

NextBio announced a multi-year collaboration with Sanofi SA, aimed at using NextBio Clinical to incorporate patient omics and clinical data into Sanofi SA's drug research and development, as part of Sanofi SA's Translational Medicine for Patients (TM4P) program. NextBio will provide Sanofi SA with the NextBio Clinical platform for aggregation, standardization and analysis of patient clinical data, next generation sequencing (NGS) and other molecular data across public data sources, Sanofi SA clinical trials and Sanofi SA hospital partners. NextBio's data integration platform, user interface and real-time Big Data analytics will allow Sanofi SA biologists and clinicians to tap into a growing collection of patient data. 

Company Quote

84.65
-0.25 -0.29%
8:36am EDT